Source | M.W. | 384.39 | CAS No. | 301836-41-9 | |
---|---|---|---|---|---|
Structural Info | 4-(5-BENZOL[1,3]DIOXOL-5-YL-4-PYRLDIN-2-YL-1H-IMIDAZOL-2-YL)-BENZAMIDE | ||||
Formulation | Powder | ||||
Reconstitution | Before reconstitution, werecommend a brief spin to drive down any material dislodged from the bottom ofthe tube. The compound is soluble inDMSO. | ||||
Stability | The powder is stable for atleast 2 year if stored at -20°C. The dissolved compound is stable for at least 1 month at 4 °C, butshould be stored in aliquots at -20 °C for longer term. Protect from light. | ||||
Purity | Greater than 98% as determined by LC/MS analysis.LC/MS and/or NMR data available upon request. | ||||
Biological Activity | |||||
Country of Origin | USA |
A selectiveinhibitor of the transforming growth factor-β (TGF-β) type I receptor activin receptor-like kinase ALK5 (IC50= 94 nM), and the related ALK4 and ALK7.Ref: Lapinget al. Inhibition of transforming growth factor (TGF)-β1-inducedextracellular matrix with a novel inhibitor of the TGF-β type I receptor kinaseactivity: SB-431542. Mol.Pharmacol. 62 58, 2002. Inmanet al. SB-431542 is a potent and specific inhibitor of transforminggrowth factor-β superfamily type I activin receptor-like kinase (ALK) receptorsALK4, ALK5, and ALK7. Mol.Pharmacol. 62 65, 2002.